PROFOUND MEDICAL CORP. (PROF) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $325.38M; Additional Paid in CapitalUSD $25.69M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $3.07M; Retained Earnings (Accumulated Deficit)USD $-304.33M.
- 2026-03-31: Common Stock, Value, IssuedUSD $324.16M; Additional Paid in CapitalUSD $26.03M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $4.02M; Retained Earnings (Accumulated Deficit)USD $-294.79M.
- 2025-12-31: Common Stock, Value, IssuedUSD $323.84M; Additional Paid in CapitalUSD $25.31M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $5.03M; Retained Earnings (Accumulated Deficit)USD $-287.74M.
- 2025-09-30: Common Stock, Value, IssuedUSD $282.75M; Additional Paid in CapitalUSD $24.21M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $4.75M; Retained Earnings (Accumulated Deficit)USD $-279.57M.
PROFOUND MEDICAL CORP. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Accumulated Other Comprehensive Income CAD | Accumulated Other Comprehensive Income USD | Retained Earnings CAD | Retained Earnings USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $325.38M | $25.69M | $3.07M | $-304.33M | $49.81M | 3 month · $874.00K | (m) | (m) | (m) | (m) |
| 2026-03-31 | $324.16M | $26.03M | $4.02M | $-294.79M | $59.42M | 3 month · $1.05M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $323.84M | $25.31M | $5.03M | $-287.74M | $66.43M | 12 month · $5.49M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $282.75M | $24.21M | $4.75M | $-279.57M | $32.14M | 3 month · $1.67M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $281.64M | $23.65M | $5.56M | $-271.59M | $39.26M | 3 month · $1.45M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $281.64M | $22.20M | $2.85M | $-255.89M | $50.79M | 3 month · $989.00K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $281.55M | $21.30M | $2.74M | $-245.17M | $60.42M | 12 month · $2.58M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | $30.72M | 3 month · $604.00K | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | $38.90M | 3 month · $768.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | $45.52M | 3 month · $767.00K | (m) | (m) | (m) | (m) |
| 2023-12-31 | $222.21M | $20.81M | $5.57M | $-217.35M | $31.22M | 12 month · $3.42M | (m) | $12.03M | (m) | $-217.93M |
| 2022-12-31 | (m) | (m) | (m) | (m) | $52.60M | (m) | (m) | $16.84M | (m) | $-189.36M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.75M | (m) | $-160.69M |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.57M | (m) | $-129.99M |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | -117.00K | $7.37M | -131.07M | $-108.37M |
| 2019-01-01 | (m) | (m) | (m) | (m) | (m) | (m) | -29.00K | $11.86M | -111.03M | $-93.27M |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | -28.70K | (m) | -111.03M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |